•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
hVIVO PLC (AIM:HVO) chief executive Yamin “Mo” Khan discussed the company’s full-year results with Proactive, focusing on financial performance, strategic progress and the outlook for 2026.
Khan said that despite a challenging macroeconomic environment, hVIVO delivered results in line with expectations. The company reported revenue of just under £47 million and a positive EBITDA of over £1 million, which he said was ahead of earlier guidance. He added that the company “was able to turn that around and achieve really a positive EBITDA,” describing it as a success for the prior year. hVIVO also maintained a cash position of more than £40 million.
A central theme was hVIVO’s diversification strategy. The company completed acquisitions, including clinical trial units in Germany and CryoStore, a UK-based business. Khan said the moves expand the company’s capabilities and therapeutic areas, creating “a one-stop shop platform” for clients across the full clinical development lifecycle.
Khan noted that the human challenge trial business faced headwinds, including cancellations linked to vaccine market volatility. However, he said the company is seeing renewed momentum, with proposal activity increasing significantly, including a 50% year-on-year rise in early 2026.
For 2026, hVIVO expects continued growth supported by its broadened service offering, a stronger sales pipeline and new client wins. Khan highlighted a contract with Traws Pharma among the new wins.
He added that the diversified platform “gives us access to many more clients,” supporting a wider addressable market and underpinning expectations for high single-digit revenue growth in 2026.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
